Robert C Wolf - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Robert C Wolf

Showing results (91-100 of 100) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 100 results.

Mayo Clinic Proceedings|February 13, 2004

Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.

Bone Marrow Transplantation|November 4, 2018

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.

American Journal of Hematology|June 30, 2019

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, M Hasib Sidiqi, Angela Dispenzieri, et al.

British Journal of Haematology|April 14, 2006

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemiaIrene M Ghobrial, Rafael Fonseca, Morie A Gertz, et al.

American Journal of Hematology|July 6, 2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosisAbdullah S Al Saleh, M Hasib Sidiqi, Surbhi Sidana, et al.

Bone Marrow Transplantation|July 6, 2020

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantationAbdullah S Al Saleh, Harsh V Parmar, Iuliana Vaxman, et al.

Bone Marrow Transplantation|May 3, 2020

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S Al Saleh, M Hasib Sidiqi, JaeWon Lee, et al.

Mayo Clinic Proceedings|October 3, 2008

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiativeMorie A Gertz, Stephen M Ansell, David Dingli, et al.

Leukemia & Lymphoma|March 12, 2020

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.

Blood Cancer Journal|June 23, 2026

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myelomaBinoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.

Pageof 10

Search research articles

Showing results (91-100 of 100) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 100 results.

Mayo Clinic Proceedings|February 13, 2004

Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.

Bone Marrow Transplantation|November 4, 2018

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.

American Journal of Hematology|June 30, 2019

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, M Hasib Sidiqi, Angela Dispenzieri, et al.

British Journal of Haematology|April 14, 2006

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemiaIrene M Ghobrial, Rafael Fonseca, Morie A Gertz, et al.

American Journal of Hematology|July 6, 2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosisAbdullah S Al Saleh, M Hasib Sidiqi, Surbhi Sidana, et al.

Bone Marrow Transplantation|July 6, 2020

Bone Marrow Transplantation|May 3, 2020

Mayo Clinic Proceedings|October 3, 2008

Leukemia & Lymphoma|March 12, 2020

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.

Blood Cancer Journal|June 23, 2026

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myelomaBinoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.

Pageof 10